Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170,107,714
-
Total 13F shares
-
116,880,555
-
Share change
-
-4,906,944
-
Total reported value
-
$1,784,761,158
-
Put/Call ratio
-
86%
-
Price per share
-
$15.27
-
Number of holders
-
178
-
Value change
-
-$131,328,718
-
Number of buys
-
97
-
Number of sells
-
102
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q2 2018
As of 30 Jun 2018,
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) was held by
178 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
116,880,555 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, OppenheimerFunds, Inc., ORBIMED ADVISORS LLC, JANUS HENDERSON GROUP PLC, Point72 Asset Management, L.P., and FIRST TRUST ADVISORS LP.
This page lists
178
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.